High-Risk Skin Cancer Surveillance in Organ Transplant Recipients
Dr. Michael Chen, MDMarch 25, 20267 min read
Why immunosuppressive medications increase skin cancer risk 100-fold and the protocols required for patient protection.
Immunosuppression and Accelerated Skin Carcinoma
Organ transplant recipients require frequent skin cancer screening every 3 to 6 months due to heightened vulnerability to squamous cell carcinomas.
This article is educational and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified dermatologist or other licensed health provider with questions about a medical condition.
Looking for a specialist in this area? Browse Ongoing Skin Surveillance & Teledermatology
